HUP0200244A3 - Use of sex hormones for producing nasal pharmaceutical compositions useful in the treatment of undesirable uterine bleeding - Google Patents
Use of sex hormones for producing nasal pharmaceutical compositions useful in the treatment of undesirable uterine bleedingInfo
- Publication number
- HUP0200244A3 HUP0200244A3 HU0200244A HUP0200244A HUP0200244A3 HU P0200244 A3 HUP0200244 A3 HU P0200244A3 HU 0200244 A HU0200244 A HU 0200244A HU P0200244 A HUP0200244 A HU P0200244A HU P0200244 A3 HUP0200244 A3 HU P0200244A3
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- pharmaceutical compositions
- compositions useful
- uterine bleeding
- sex hormones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9904022A FR2791572A1 (fr) | 1999-03-31 | 1999-03-31 | Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200244A2 HUP0200244A2 (hu) | 2002-07-29 |
| HUP0200244A3 true HUP0200244A3 (en) | 2003-05-28 |
Family
ID=9543854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200244A HUP0200244A3 (en) | 1999-03-31 | 2000-03-30 | Use of sex hormones for producing nasal pharmaceutical compositions useful in the treatment of undesirable uterine bleeding |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1143978A2 (no) |
| JP (1) | JP2002541076A (no) |
| KR (1) | KR20010102464A (no) |
| CN (1) | CN1346273A (no) |
| AU (1) | AU3662300A (no) |
| BR (1) | BR0008577A (no) |
| CA (1) | CA2361885A1 (no) |
| EA (1) | EA200100801A1 (no) |
| FR (1) | FR2791572A1 (no) |
| HK (1) | HK1044486A1 (no) |
| HU (1) | HUP0200244A3 (no) |
| NO (1) | NO20014022L (no) |
| NZ (1) | NZ513672A (no) |
| PL (1) | PL356767A1 (no) |
| WO (1) | WO2000059447A2 (no) |
| ZA (1) | ZA200106689B (no) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383993A (en) * | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
| NL8801670A (nl) * | 1988-07-01 | 1990-02-01 | Walter Adrianus Josephus Johan | Farmaceutisch preparaat. |
| US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| NZ333671A (en) * | 1996-07-23 | 2000-07-28 | Pherin Pharm Inc | use of steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
-
1999
- 1999-03-31 FR FR9904022A patent/FR2791572A1/fr not_active Withdrawn
-
2000
- 2000-03-30 HK HK02106208.3A patent/HK1044486A1/zh unknown
- 2000-03-30 EP EP00915247A patent/EP1143978A2/fr not_active Withdrawn
- 2000-03-30 EA EA200100801A patent/EA200100801A1/ru unknown
- 2000-03-30 PL PL00356767A patent/PL356767A1/xx not_active Application Discontinuation
- 2000-03-30 WO PCT/FR2000/000790 patent/WO2000059447A2/fr not_active Ceased
- 2000-03-30 CN CN00804471A patent/CN1346273A/zh active Pending
- 2000-03-30 KR KR1020017011124A patent/KR20010102464A/ko not_active Ceased
- 2000-03-30 JP JP2000609012A patent/JP2002541076A/ja active Pending
- 2000-03-30 CA CA002361885A patent/CA2361885A1/fr not_active Abandoned
- 2000-03-30 BR BR0008577-4A patent/BR0008577A/pt not_active IP Right Cessation
- 2000-03-30 AU AU36623/00A patent/AU3662300A/en not_active Abandoned
- 2000-03-30 NZ NZ513672A patent/NZ513672A/xx not_active Application Discontinuation
- 2000-03-30 HU HU0200244A patent/HUP0200244A3/hu unknown
-
2001
- 2001-08-14 ZA ZA200106689A patent/ZA200106689B/en unknown
- 2001-08-17 NO NO20014022A patent/NO20014022L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2361885A1 (fr) | 2000-10-12 |
| PL356767A1 (pl) | 2004-07-12 |
| NZ513672A (en) | 2001-09-28 |
| WO2000059447A3 (fr) | 2001-04-26 |
| HK1044486A1 (zh) | 2002-10-25 |
| KR20010102464A (ko) | 2001-11-15 |
| HUP0200244A2 (hu) | 2002-07-29 |
| BR0008577A (pt) | 2002-10-01 |
| EP1143978A2 (fr) | 2001-10-17 |
| CN1346273A (zh) | 2002-04-24 |
| EA200100801A1 (ru) | 2002-04-25 |
| FR2791572A1 (fr) | 2000-10-06 |
| NO20014022D0 (no) | 2001-08-17 |
| JP2002541076A (ja) | 2002-12-03 |
| AU3662300A (en) | 2000-10-23 |
| NO20014022L (no) | 2001-08-17 |
| WO2000059447A2 (fr) | 2000-10-12 |
| ZA200106689B (en) | 2002-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021020I1 (el) | Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη | |
| HU0103558D0 (en) | Pharmaceutical composition for the treatment of stroke and traumatic brain insury | |
| HUP0103494A2 (en) | Process for intermittent administration use of growth hormone secretagogues for the manufacture of pharmaceutical compositions for intermittent administration and kit comprising thereof | |
| HUP0401192A3 (en) | Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds | |
| HUP0200264A3 (en) | Use of estrogen agonists/antagonists for producing pharmaceutical compositions suitable for the treatment of cancers | |
| HUP0203437A3 (en) | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases | |
| MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| IL211288A (en) | Medical vaginal preparations to reduce or relieve uterine rhythm, and use of anti-arrhythmic therapy in the preparation of vaginal drugs to reduce or relieve uterine rhythm | |
| HUP0204399A3 (en) | Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use | |
| EP1404343A4 (en) | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | |
| IL164896A (en) | Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors | |
| HUP0201187A3 (en) | Use of ecteinascidin743 for producing pharmaceutical compositions suitable for treating cancer | |
| HUP0202233A3 (en) | Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them | |
| HUP0301460A3 (en) | Use of antiprogestins for producing pharmaceutical compositions for prohylaxis and treatment of hormone-dependent diseases | |
| HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
| HUP0402323A3 (en) | Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same | |
| HUP0102159A3 (en) | Pharmaceutical composition for the treatment of rumen acidosis | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| HUP0201405A3 (en) | Pharmaceutical composition for therapeutic use of melatonin | |
| HUP0402023A3 (en) | Use of anastrozole in the preparation of pharmaceutical compositions for the treatment of post-menopausal women having early breast cancer | |
| HUP0500958A2 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them | |
| HUP0303910A3 (en) | Use of kapp-opiate agonists for preparation of pharmaceutical composition for the treatment of bladder dieseases | |
| IL137275A0 (en) | Pharmaceutical composition for the treatment of anal fissures | |
| IL156045A0 (en) | Compositions containing gangliosides for use in the treatment of skin disorders | |
| GB0312566D0 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin |